We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

OSI-906 and Irinotecan in Patients With Advanced Cancer

This study has been terminated.
(This study was discontinued due to a shown lack of efficacy in the investigational agent)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01016860
First Posted: November 20, 2009
Last Update Posted: October 21, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Colorado, Denver
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2013
  Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)